Immune approaches in tuberculosis therapy: a brief overview-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune approaches in tuberculosis therapy: a brief overview

Published:2012-03 Issue:3 Volume:10 Page:381-389
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Bourinbaiar Aldar S,Mezentseva Marina V,Butov Dmitry A,Nyasulu Peter S,Efremenko Yuri V,Jirathitikal Vichai,Mishchenko Vladimir V,Kutsyna Galyna A

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

http://www.tandfonline.com/doi/pdf/10.1586/eri.12.1

Reference45 articles.

1. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products

2. Cohen J.Shots in the Dark: The Wayward Search for an AIDS Vaccine.W.W Norton & Company, London, UK (2001).

3. Introduction. Rational vaccine development against tuberculosis: “Those who don't remember the past are condemned to repeat it”

4. Tuberculin immunotherapy: its history and lessons to be learned

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Approaches in Tuberculosis Treatment;Integrated Science;2023

2. Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2020-02

3. Tuberculosis: History, Epidemiology, Antitubercular Drugs and Plant-based Alternatives;INDIAN J PHARM SCI;2019

4. Effectiveness of anti-tuberculosis chemotherapy in patients with tuberculosis relapse compared with newly diagnosed patients;International Journal of Mycobacteriology;2019

5. Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L;Journal of Hepatocellular Carcinoma;2017-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3